Swiss company develops a Fever Detection Algorithm Based on Non-invasive Skin-based Sensor Values in Infants up to 18 Months of Age

Photo by Marcus Wallis

The company greenTEG AG is conducting the clinical trial Development of a Fever Detection Algorithm Based on Non-invasive Skin-based Sensor Values in Infants up to 18 Months of Age.

Fever of infants up to 18 months of age will be monitored in the hospital using the standard clinical methods and wearable research prototypes. These research prototypes will be measuring continuously and non-invasively skin based parameters, with which the feasibility of developing a fever detection algorithm will be investigated.

Actual study start date is April 7, 2020. The researchers expect to complete the study by May 31, 2021.

The population that can be enrolled into this study includes:

• Infants from two weeks after birth and due date up to 18 months of age.
• Infants which are staying at the Nursery and the University Children's Hospital Zurich for more than 1 day.
• Informed consent signed by parents or by legal representatives

Among the exclusion criteria are:

• Acute medical contradiction against medical plaster and adhesives (e.g. skin diseases or allergies).
• Irritated or damaged skin (e.g. burn, rush, eczema).
• Infant with congenital anomalies (e.g. malformations of the anus).
• Disease or brain injury which cause a disturbance of the thermoregulation.
• Comatose infant's.
• Infants with implants (e.g. pacemaker, cochlear implants)

The location of the study is as follows (further details can be found here https://ichgcp.net/clinical-trials-registry/NCT04654559) Zurich, Switzerland.